Century Therapeutics, Inc.
IPSC- 交易所
- Nasdaq
- 產業
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850119
近 90 天，Century Therapeutics, Inc. 內部人申報 0 筆公開市場買進、5 筆賣出；2026 年第 2 季末有 100 家機構在 13F 申報持有，市值合計 $3.87 億；沒有大師持有。
SEC 申報
Century Therapeutics, Inc. 向 SEC 申報的 10-K、10-Q、8-K、20-F、40-F，最新的在前。
Livermore 只列出每份申報的表單、8-K 的 Item 與日期。內文請到 SEC 網站讀；8-K 的新聞稿等附件（例如 Item 2.02 的 EX-99.1）在申報目錄裡。
| 申報日 | 表單 | 8-K 的 Item | 期間 | 原文 | 申報目錄 |
|---|---|---|---|---|---|
| 2026/10/2 | 8-K | 7.018.019.01 | 2026/10/2 | SEC | 目錄 |
| 2026/9/9 | 8-K | 5.027.019.01 | 2026/9/9 | SEC | 目錄 |
| 2026/8/12 | 8-K | 2.027.019.01 | 2026/8/12 | SEC | 目錄 |
| 2026/8/12 | 10-Q | – | 2026/6/30 | SEC | 目錄 |
| 2026/6/16 | 8-K | 5.02 | 2026/6/15 | SEC | 目錄 |
| 2026/6/12 | 8-K | 5.035.079.01 | 2026/6/11 | SEC | 目錄 |
| 2026/6/8 | 8-K | 8.019.01 | 2026/6/8 | SEC | 目錄 |
| 2026/5/13 | 8-K | 2.029.01 | 2026/5/13 | SEC | 目錄 |
| 2026/5/13 | 10-Q | – | 2026/3/31 | SEC | 目錄 |
| 2026/3/26 | 8-K | 8.019.01 | 2026/3/26 | SEC | 目錄 |
| 2026/3/12 | 8-K | 2.027.019.01 | 2026/3/12 | SEC | 目錄 |
| 2026/3/12 | 10-K | – | 2025/12/31 | SEC | 目錄 |
| 2026/1/23 | 8-K | 5.078.01 | 2026/1/22 | SEC | 目錄 |
| 2026/1/12 | 8-K | 7.019.01 | 2026/1/12 | SEC | 目錄 |
| 2026/1/8 | 8-K | 1.013.027.019.01 | 2026/1/7 | SEC | 目錄 |
| 2025/12/29 | 8-K | 5.02 | 2025/12/18 | SEC | 目錄 |
| 2025/12/12 | 8-K | 7.019.01 | 2025/12/12 | SEC | 目錄 |
| 2025/12/9 | 8-K | 5.027.019.01 | 2025/12/9 | SEC | 目錄 |
| 2025/11/13 | 8-K | 2.027.018.019.01 | 2025/11/13 | SEC | 目錄 |
| 2025/11/13 | 10-Q | – | 2025/9/30 | SEC | 目錄 |
| 2025/8/29 | 8-K | 3.01 | 2025/8/27 | SEC | 目錄 |
| 2025/8/14 | 10-Q | – | 2025/6/30 | SEC | 目錄 |
| 2025/8/14 | 8-K | 2.025.027.019.01 | 2025/8/13 | SEC | 目錄 |
| 2025/7/7 | 8-K | 2.055.02 | 2025/7/1 | SEC | 目錄 |
| 2025/6/16 | 8-K | 5.07 | 2025/6/12 | SEC | 目錄 |
| 2025/5/15 | 10-Q | – | 2025/3/31 | SEC | 目錄 |
| 2025/5/15 | 8-K | 2.027.019.01 | 2025/5/15 | SEC | 目錄 |
| 2025/3/19 | 10-K | – | 2024/12/31 | SEC | 目錄 |
| 2025/3/19 | 8-K | 2.027.019.01 | 2025/3/19 | SEC | 目錄 |
| 2025/2/28 | 8-K | 3.01 | 2025/2/26 | SEC | 目錄 |
| 2025/1/13 | 8-K | 2.027.019.01 | 2025/1/13 | SEC | 目錄 |
| 2024/12/13 | 8-K | 1.02 | 2024/12/12 | SEC | 目錄 |
| 2024/11/5 | 10-Q | – | 2024/9/30 | SEC | 目錄 |
| 2024/11/5 | 8-K | 2.028.019.01 | 2024/11/5 | SEC | 目錄 |
| 2024/9/26 | 8-K | 5.02 | 2024/9/26 | SEC | 目錄 |
| 2024/8/8 | 10-Q | – | 2024/6/30 | SEC | 目錄 |
| 2024/8/8 | 8-K | 2.027.019.01 | 2024/8/8 | SEC | 目錄 |
| 2024/7/8 | 8-K | 8.019.01 | 2024/7/8 | SEC | 目錄 |
| 2024/6/26 | 8-K/A | 9.01 | 2024/4/11 | SEC | 目錄 |
| 2024/6/24 | 8-K | 5.07 | 2024/6/20 | SEC | 目錄 |
| 2024/6/3 | 8-K | 8.019.01 | 2024/6/3 | SEC | 目錄 |
| 2024/5/9 | 10-Q | – | 2024/3/31 | SEC | 目錄 |
| 2024/5/9 | 8-K | 2.029.01 | 2024/5/9 | SEC | 目錄 |
| 2024/4/11 | 8-K | 2.013.027.019.01 | 2024/4/11 | SEC | 目錄 |
| 2024/4/11 | 8-K | 8.019.01 | 2024/4/11 | SEC | 目錄 |
| 2024/4/9 | 8-K | 8.019.01 | 2024/4/8 | SEC | 目錄 |
| 2024/3/14 | 10-K | – | 2023/12/31 | SEC | 目錄 |
| 2024/3/14 | 8-K | 2.027.019.01 | 2024/3/14 | SEC | 目錄 |
| 2024/1/19 | 8-K | 5.02 | 2024/1/15 | SEC | 目錄 |
| 2023/12/11 | 8-K | 8.019.01 | 2023/12/9 | SEC | 目錄 |